Direct costs of first‐generation protease inhibitors for the treatment of genotype 1 chronic hepatitis C viral infection

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|12|974-976

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.12, 2015-12, pp. : 974-976

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dermatitis induced by first‐generation hepatitis C virus protease inhibitors

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 311-312

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variations in the Viral NS5B Region in Japanese Patients with Chronic Hepatitis C Virus Genotype 1b Infection

By  

Intervirology, Vol. 49, Iss. 6, 2006-10 ,pp. : 319-326

Karger

Access to resources Recommend Favorite

Work productivity among treatment‐naïve patients with genotype 1 chronic hepatitis C infection receiving telaprevir combination treatment

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 1, 2015-01 ,pp. : 8-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis

By Cooper C.  

QJM: An International Journal of Medicine, Vol. 106, Iss. 2, 2013-02 ,pp. : 153-163

Oxford University Press

Access to resources Recommend Favorite

Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infection

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 1478-3223, Iss. 10, 2015-10 ,pp. : 2256-2264

John Wiley & Sons Inc

Access to resources Recommend Favorite